- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04036591
Use Of The ABSS In Infants With ARIS Treated With Outpatient Respiratory Physiotherapy
Use Of The "Acute Bronchiolitis Severity Scale" In Infants With Acute Respiratory Infection Susceptible To Outpatient Respiratory PhysiotherapyTreatment
Background. Acute respiratory infections in childhood have high incidence and morbimortality rates, generating significant sanitary and social costs. Due to its diversity of manifestations and clinical forms, the degree of severity varies widely.
Published acute respiratory infections assessment severity scales are mainly focused on acute bronchiolitis, but there is no validated scale to evaluate the effects of respiratory physiotherapy in acute respiratory infections in children.
Objective. To study the usefulness of the Acute Bronchiolitis Severity Scale to assess children under 24 months suffering from acute respiratory infections susceptible to receive outpatient respiratory physiotherapy treatment.
Methods. Pre-post assessment descriptive study using the Acute Bronchiolitis Severity Scale. Children under 24 months suffering from acute respiratory infection will be evaluated during the first outpatient respiratory physiotherapy treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Beatriz Simón Rodríguez
- Phone Number: 0034629441102
- Email: beatriz_simon@fisiorespiracion.es
Study Locations
-
-
-
Madrid, Spain, 28049
- Recruiting
- FisioRespiración
-
Contact:
- Beatriz Simón Rodríguez
- Phone Number: 0034629441102
- Email: beatriz_simon@fisiorespiracion.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Under 24 months
- ARIS diagnosed
- Medical indication of respiratory physiotherapy
- Evaluated during the first outpatient respiratory physiotherapy treatment
Exclusion Criteria:
- Chronic desease
- ABSS ≥ 7
- Temperature≥ 38ºC
- Stridor
- Expiratory groan
- Sternal sinking
- Any sign or symptom indicative of need for urgent medical evaluation
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Children under 24 months with ARIS
|
All infants will be assessed using the Acute Bronchiolitis Severity Scale (ABSS) before and after being treated by experienced physiotherapists using the prolonged slow expiration technique and provoqued cough.
Before the application of these techniques a retrograde rhinopharyngeal unclogging will be performed in order to clean the nasopharynx.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Usefulness of Acute Bronchiolitis Severity Score (ABSS) to asses children under 24 months suffering from acute respiratory infection susceptible to receive outpatient respiratory physiotherapy treatment.
Time Frame: Through study completion, an average of 2 years.
|
Physiotherapists will use the Acute Bronchiolitis Severity Score (ABSS) to assess severity of infection pre and post treatment.
After several assessments each one of them will inform about the usefulness and aplicability of the scale in outpatient respiratory physiotherapy treatment by filling in a likert scale (usefulness, aplicability, simplicity, time required...)
|
Through study completion, an average of 2 years.
|
Immediate effectiveness of outpatient respiratory physiotherapy treatment.
Time Frame: Measurements will be taken during the outpatient respiratory physiotherapy treatment, 1 hour approximately. Pre treatment data will be collected before starting the treatment and post data 5 minutes after finishing the last manouver.
|
Change from baseline in the Acute Bronchiolitis Severity Score (ABSS) punctuation at the end of outpatient respiratory physiotherapy treatment (pre-post treatment measurement of the scale). The ABSS is a validated scale in a Spanish population that combines the evaluation of heart and respiratory rate, wheezings, crackles, respiratory effort and inspiration/exhalation ratio. It has three levels of severity: mild (0 to 4 points), moderate (5 to 9) and severe (10 to 13). |
Measurements will be taken during the outpatient respiratory physiotherapy treatment, 1 hour approximately. Pre treatment data will be collected before starting the treatment and post data 5 minutes after finishing the last manouver.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19/058-E_TFM
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Disease Respiratory
-
University of Southern DenmarkOdense University Hospital; Region of Southern Denmark; Odense Patient Data Explorative... and other collaboratorsCompletedAcute Illness | Acute Respiratory DiseaseDenmark
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedAcute Bronchitis | Upper Respiratory Tract Infection | Acute BronchiolitisSpain
-
Fundación Santa Fe de BogotaFedesarrollo; Pontificia Universidad Javeriana; Global Development NetworkCompletedAcute Respiratory Infection | Acute Diarrheal DiseaseColombia
-
University of OsloUnknownFebrile Illness | Acute Respiratory Disease | Acute Cardiovascular DiseaseNorway
-
Altesa Biosciences, Inc.Virtus Respiratory ResearchRecruitingRCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionInfections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Lung Diseases | Pulmonary Disease, Chronic Obstructive | Enterovirus Infections | Copd | Pulmonary Disease | Respiratory Disease | Respiratory Complication | Upper Respiratory Tract Infections | Respiratory Viral Infection | ... and other conditionsUnited Kingdom
-
Hanlim Pharm. Co., Ltd.CompletedAcute Exacerbations of Chronic Bronchitis | Acute BronchitisKorea, Republic of
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.Not yet recruiting
-
University of Iowa3MWithdrawnSARS-CoV-2 Acute Respiratory Disease
-
Hasselt UniversityRecruitingAcute Exacerbation of COPD | Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseBelgium
-
Everly HealthCompletedSARS-CoV-2 Acute Respiratory DiseaseUnited States
Clinical Trials on Acute Bronchiolitis Severity Scale (ABSS)
-
University Hospital, MontpellierINSERM U1061 MontpellierRecruitingSomnolence Disorder, ExcessiveFrance
-
Ankara City Hospital BilkentCompletedAcute Renal Failure | COVID19Turkey
-
Pamukkale UniversityCompletedBody Composition | Cerebrovascular StrokeTurkey
-
Institut d'Investigació Biomèdica de Girona Dr....CompletedSeverity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women (MANOPRESS)Fecal Incontinence | Anal; Sphincter, Incontinence | Incontinence, UrgeSpain
-
Centre Hospitalier Universitaire DijonCompletedSymptomatic Cerebral InfarctionFrance
-
University Hospital Schleswig-HolsteinZealand University HospitalNot yet recruitingBreast Cancer FemaleGermany
-
Kırıkkale UniversityCompletedChronic Obstructive Pulmonary DiseaseTurkey
-
Dr. Rebecca SchuleGerman Federal Ministry of Education and Research; German Center for Neurodegenerative...RecruitingHereditary Spastic ParaplegiaAustria, Germany, Italy
-
Dr. Rebecca SchuleGerman Research Foundation; German Center for Neurodegenerative Diseases (DZNE)RecruitingSpastic AtaxiaCanada, France, Germany, Italy, Netherlands, Turkey, United Kingdom
-
Konya Beyhekim Training and Research HospitalCompleted